novartis

This study aims to assess the new film-coated tablet formulation to the currently approved dispersible tablet formulation with regards to overall safety, Gastrointestinal (GI) tolerability, palatability, satisfaction and compliance.

More information: clinicaltrials.gov, ITHANET Clinical Trials

ITHANET Newsletter

Please, provide your details in order to receive our regular e-Newsletter.

Future Events

No future events

View all events